Renewing Investment in American Workers and Supply Chains Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome
Client expense: Not reported · Firm income: $10,000
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Budget/Appropriations
H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 8774/S.4921, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S. 4924, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Budget/Appropriations
H.R. 8774/S.4921, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance; H.R. 7542/S. 3757, Stop CMV Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Budget/Appropriations
H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 8774/S.4921, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S.4924, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE